Navigation Links
Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing targeted monoclonal antibodies for the treatment of cancer and hepatitis C virus infection, today announced initiation of a new clinical trial designed to evaluate the safety and efficacy of its tumor necrosis therapy (TNT) agent Cotara(R) in patients with glioblastoma multiforme (GBM), a deadly form of brain cancer.

In pilot studies Cotara has shown encouraging results, demonstrating a 58% increase in the expected median survival time in a group of 28 patients suffering from recurrent late stage glioblastoma multiforme. This was considered a promising development in this serious and deadly disease, which kills half of its victims within 14 months of diagnosis.

Peregrine believes that combined positive data from this new study in India and ongoing U.S. glioblastoma trials would provide a foundation for advancing Cotara into Phase III trials.

"Cotara has demonstrated promising increases in survival in previous clinical studies of late stage glioblastoma patients, and we are optimistic that the very large population of glioblastoma patients served by our Indian study centers will facilitate timely enrollment in this important new trial," said Steven W. King, president and CEO of Peregrine. "We anticipate that positive data from this study, together with dosimetry and dosing data being collected in ongoing U.S. Cotara trials, will help us determine the optimal design of Phase III product registration trials."

This multi-center open label Phase II safety and efficacy study is designed to enroll up to 40 glioblastoma patients who have experienced a first relapse. The study's primary objective is to confirm the maximum tolerated dose of Cotara in patients with GBM at first relapse.

Secondary objectives include estimates of overall patient survival, progression free survival and the proportion of patien
'"/>




Page: 1 2

Related medicine news :

1. FDA approves Watson Pharmaceuticals Oxytrol patch
2. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
3. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
4. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
5. Top Pharmaceuticals Influence Doctors Prescriptions
6. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
7. Personalized Medicine and Innovative Pharmaceuticals
8. Pravastatin Launched by Watson Pharmaceuticals
9. Tata Industries picks up stake in Indigene Pharmaceuticals
10. Pharmaceuticals May not Pose Major Aquatic Environmental Risks
11. OPPI Opposes Draft National Pharmaceuticals Policy
Post Your Comments:
(Date:7/27/2015)... California (PRWEB) , ... July 27, 2015 , ... ... Addiction Treatment Center has added hiking to its options. Already an ... Serenity Palms is constantly on the lookout for the latest successful trends in ...
(Date:7/27/2015)... ... 2015 , ... Throughout its 20 year history, Doctors on Liens ... a lien basis. As the personal injury and medical industries have changed, Doctors ... orthopedists, to pain management physicians, to psychologists and more. And while many of ...
(Date:7/27/2015)... ... 2015 , ... For a limited time, Huntington Beach dentist , Dr. ... a great time to change up a look or to simply brighten a smile. ... your self-esteem. Over time, the enamel coating can become worn and can expose more ...
(Date:7/27/2015)... ... July 27, 2015 , ... In a creative effort ... help restore a healthy lifestyle, The Ranch at Dove Tree in Lubbock has shared ... readers easily through the steps of recovery. Both the nationally recognized collegiate program and ...
(Date:7/27/2015)... ... July 27, 2015 , ... Dentist in Los Angeles , Dr. Poneh Ghasri, is now ... new beginnings for many people. Teeth whitening can help brighten up a person’s look, help ... is the safest and most effective way to get a whiter smile. Dr. Ghasri, ...
Breaking Medicine News(10 mins):Health News:Hiking Adds Benefits to Recovery at Serenity Palms 2Health News:Hiking Adds Benefits to Recovery at Serenity Palms 3Health News:Doctors on Liens Adds Highly Respected Physical Therapy Office in Los Angeles 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 2Health News:Huntington Beach Cosmetic Dentist, Dr. Rassouli, is Now Offering a Summer Promotion on Zoom Whitening 3Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 2Health News:The Ranch At Dove Tree Infographic Enlightens Process Of Recovery 3Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Is Now Offering a Teeth Whitening Special Just in Time for Summer 2
... Treatment-Experienced ... Patients, ... a national organization of HIV-treating physicians, nurse,practitioners and physician assistants, praised ... medication TMC125,(etravirine), the first non-nucleoside reverse transcriptase inhibitor,(NNRTI) to be introduced ...
... by Mail System(R) and other products reach $3.8 million; revenue increased ... pharmaceutical and hospitality markets - Strong operating leverage shows in sequential ... expected in third ... quarter fiscal 2008, - Purchase of medical ...
... /Xinhua-PRNewswire/ -- The Red Cross Society of Beijing,has ... in China, to,launch online donation service for snow ... for snow storm victims in disaster areas. The,donation ... ., (Logo: http://www.newscom.com/cgi-bin/prnh/20051211/CNM005 ), ...
... Americans,are plagued by high cholesterol, which can lead to chronic ... Americans take the,idea of Fat Tuesday and Carnival to heart ... has its roots in the Latin phrase "carne vale." Literally,say ... can be a big,step towards living healthier. Cutting back on ...
... on Improving Drought Tolerance, DES MOINES, Iowa, ... convened here today for a three-day project review,meeting ... by DuPont,(NYSE: DD ) business Pioneer-Hi-Bred, the ... among public and private organizations in order to,help ...
... Customer Satisfaction Eight Consecutive ... Quarters, According to MD Buyline, NASHUA, N.H., ... Computer-Aided Detection (CAD),solutions for the early identification of cancer, today ... satisfaction, according to,the independent healthcare research group MD Buyline., ...
Cached Medicine News:Health News:AAHIVM Encouraged by TMC125 Approval 2Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 2Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 3Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 4Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 5Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 6Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 7Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 8Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 9Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 10Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 11Health News:Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008 12Health News:Red Cross Partners with YeePay on China Snow Disaster Relief 2Health News:Mardi Gras Means Lean Times Ahead But That Doesn't Mean the Party's Over 2Health News:DuPont Hosts Meeting of Leading Plant Scientists to Improve World Agricultural Productivity 2Health News:iCAD Ranks #1 in Mammography CAD User Satisfaction 2Health News:iCAD Ranks #1 in Mammography CAD User Satisfaction 3
(Date:7/27/2015)... , July 20, 2015 Research ... addition of the "Key Pharma News Issue" ... This acquisition bolsters Gilead Sciences, burgeoning oncology pipeline ... will make further oncology deals in 2015, with ... of 2016. Key Pharma News ...
(Date:7/27/2015)... Varian Medical Systems UK Ltd announced today it had signed ... two new national NHS proton therapy centers in ... therapy system. Earlier this year, Varian announced that it was ... to be constructed in London and ... equipment portion of the order in its fiscal fourth quarter ...
(Date:7/27/2015)... Prospects for Development, Manufacturing and ... Top Companies, Revenue Prospects Now, Benefiting Your Influence ,What ... generic medicines ? Visiongain ,s new report ... lets you discover results, trends, opportunities and revenue forecasts, ... leading producers and marketers of generic drugs, you find ...
Breaking Medicine Technology:Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 2Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 3Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 4Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 2Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 3Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 4Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 5Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 6Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 7Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 8Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 9
... Oct. 13, 2011 K-V Pharmaceutical Company (the ... of Obstetricians and Gynecologists (ACOG) and Society for ... that ensures healthcare providers, patients, and the payer ... information update emphasizes that previous ACOG and SMFM ...
... 13, 2011 IVD Technology , ... diagnostics technologies including research, development, and manufacturing, today announced ... emerging trend in the industry – ... (CONTACT:   http://photos.prnewswire.com/prnh/20101214/LA16070LOGO ) The featured speaker ...
Cached Medicine Technology:K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 2K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 3K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 4K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 5K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 6K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 7K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P 8Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 2Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 3